logo
  

Jungheinrich Supervisory Chairman Hans-Georg Frey To Resign

Jungheinrich AG said that Hans-Georg Frey decided to resign as member and also as Chairman of the Supervisory Board with effect from the end of the Annual General Meeting on 11 May 2023.

"After almost 16 years leading Jungheinrich, of which twelve were as Chairman of the Board of Management and almost four years as Chairman of the Supervisory Board, the time has come for me to make a change," said Hans-Georg Frey.

Hans-Georg noted that the early announcement makes it possible for the company to initiate a professional process and arrange for a successor.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
RELATED NEWS
Follow RTT